US › Healthcare

Biomotion Sciences Ordinary Shares (SLXN)

US · Healthcare · Biotechnology

$0.38+11.76%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.6M

EPS

$-5.17

EPS estimate

$-2.12

EPS came in at -5.17 against a street estimate of -2.12 — a miss of 143.9%.

Key statistics

Market cap

$2.3M

Forward P/E

0.0

P/B

44.17

Book value

$0.01

EPS (TTM)

$-23.97

52-week high

$42.60

52-week low

$0.34

50-day MA

$1.52

200-day MA

$11.19

Beta

-0.36

Analyst view

Analysts rate Biomotion Sciences Ordinary Shares a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $60.00.

Shareholding

Insiders

27.39%

Institutions

0.56%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.24%
TWO SIGMA SECURITIES, LLC	0.14%
A. Montag & Associates Inc	0.03%
UBS Group AG	0.01%
Pflug Koory, LLC.	0.00%
JONES FINANCIAL COMPANIES LLLP	0.00%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biomotion Sciences Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.